Renaissance Technologies’s Escalon Medical Corp ESMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-225,900
Closed -$151K 3652
2016
Q3
$151K Buy
225,900
+3,300
+1% +$2.38K ﹤0.01% 3121
2016
Q2
$174K Buy
222,600
+900
+0.4% +$692 ﹤0.01% 3075
2016
Q1
$177K Buy
221,700
+1,100
+0.5% +$1.02K ﹤0.01% 3123
2015
Q4
$234K Buy
220,600
+1,800
+0.8% +$1.97K ﹤0.01% 2957
2015
Q3
$254K Buy
218,800
+1,300
+0.6% +$1.69K ﹤0.01% 2834
2015
Q2
$309K Buy
217,500
+300
+0.1% +$417 ﹤0.01% 2874
2015
Q1
$293K Hold
217,200
﹤0.01% 2774
2014
Q4
$350K Buy
217,200
+1,700
+0.8% +$2.43K ﹤0.01% 2531
2014
Q3
$325K Buy
215,500
+2,600
+1% +$4.38K ﹤0.01% 2442
2014
Q2
$364K Buy
212,900
+6,500
+3% +$10.1K ﹤0.01% 2416
2014
Q1
$316K Buy
206,400
+2,700
+1% +$4.76K ﹤0.01% 2507
2013
Q4
$401K Buy
203,700
+300
+0.1% +$485 ﹤0.01% 2419
2013
Q3
$305K Sell
203,400
-300
-0.1% -$406 ﹤0.01% 2464
2013
Q2
$273K Buy
+203,700
New +$242K ﹤0.01% 2431

Other funds holding ESMC

Renaissance Technologies's ESMC Position: Q4 2016 in Review

Renaissance Technologies sold out of Escalon Medical Corp (ESMC) in Q4 2016, closing a stake of 225,900 shares — an estimated $151K sold.

Renaissance Technologies first reported a position in ESMC in Q2 2013 and held it in 14 quarters. The position peaked at $401K in Q4 2013. 3 funds tracked by Wall St. Rank hold ESMC as of Q4 2016.

  • Renaissance Technologies reported no remaining Escalon Medical Corp position as of Q4 2016 after selling out during the quarter.
  • Renaissance Technologies sold 225,900 Escalon Medical Corp shares in Q4 2016, an estimated $151K.
  • Renaissance Technologies first reported a position in Escalon Medical Corp in Q2 2013 and held it in 14 quarters.
  • Renaissance Technologies's Escalon Medical Corp position peaked at $401K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held Escalon Medical Corp as of Q4 2016.

Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.